Literature DB >> 299747

Immunoinhibition of ristocetin-induced platelet aggregation.

R L Nachman, E A Jaffe, B B Weksler.   

Abstract

Human platelets washed and fixed in paraformaldehyde aggregate in the presence of the antibiotic ristocetin and normal plasma. This aggregation response is abolished after digestion of the fixed platelets with chymotrypsin. Antisera to fixed washed platelets were produced in rabbits and absorbed with chymotrypsin-treated, fixed washed platelets. Monovalent Fab fragments obtained from the isolated gamma-globulin fractions of the antisera blocked ristocetin-induced aggregation of fixed washed platelets in buffer and normal platelets in platelet-rich plasma. By double-antibody immunoprecipitation, it was shown that the antibody which blocked the ristocetin reaction interacted with a platelet membrane surface protein of mol wt 155,000. The results suggest that the glycoprotein I complex on the surface of the human platelet mediates ristocetin-induced von Willebrand factor-dependent platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 299747      PMCID: PMC333341          DOI: 10.1172/JCI108612

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants.

Authors:  H R Gralnick; B S Coller; Y Sultan
Journal:  Science       Date:  1976-04-02       Impact factor: 47.728

2.  Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.

Authors:  C S Jenkins; D R Phillips; K J Clemetson; D Meyer; M J Larrieu; E F Lüscher
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

3.  Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein.

Authors:  J P Caen; A T Nurden; C Jeanneau; H Michel; G Tobelem; S Levy-Toledano; Y Sultan; F Valensi; J Bernard
Journal:  J Lab Clin Med       Date:  1976-04

4.  Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes.

Authors:  D R Phillips; C S Jenkins; E F Lüscher; M Larrieu
Journal:  Nature       Date:  1975-10-16       Impact factor: 49.962

5.  Specific roles for platelet surface glycoproteins in platelet function.

Authors:  A T Nurden; J P Caen
Journal:  Nature       Date:  1975-06-26       Impact factor: 49.962

6.  Platelet thrombosthenin: subcellular localization and function.

Authors:  R L Nachman; A J Marcus; L B Safier
Journal:  J Clin Invest       Date:  1967-08       Impact factor: 14.808

7.  Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.

Authors:  J P Allain; H A Cooper; R H Wagner; K M Brinkhous
Journal:  J Lab Clin Med       Date:  1975-02

8.  Platelet glycocalicin: a single receptor for platelet aggregation induced by thrombin or ristocetin.

Authors:  T Okumura; G A Jamieson
Journal:  Thromb Res       Date:  1976-05       Impact factor: 3.944

9.  Role of surface glycoproteins in human platelet function.

Authors:  A T Nurden; J P Caen
Journal:  Thromb Haemost       Date:  1976-02-29       Impact factor: 5.249

10.  Subcellular platelet factor VIII antigen and von Willebrand factor.

Authors:  R L Nachman; E A Jaffe
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

View more
  14 in total

1.  Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.

Authors:  K J Kao; S V Pizzo; P A McKee
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

2.  Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G.

Authors:  A Moore; G D Ross; R L Nachman
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

3.  Cloning and characterization of two cDNAs coding for human von Willebrand factor.

Authors:  J E Sadler; B B Shelton-Inloes; J M Sorace; J M Harlan; K Titani; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

4.  Structural analysis of human platelet membrane glycoprotein I complex.

Authors:  R L Nachman; T Kinoshita; B Ferris
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

5.  Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen.

Authors:  R L Nachman; L L Leung
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

6.  Identification of the thrombin receptor on human platelets by chemical crosslinking.

Authors:  J Takamatsu; M K Horne; H R Gralnick
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

7.  Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.

Authors:  K J Kao; S V Pizzo; P A McKee
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

8.  Human platelet membrane receptor for bovine von Willebrand factor (platelet aggregating factor): an integral membrane glycoprotein.

Authors:  H A Cooper; K J Clemetson; E F Lüscher
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

9.  Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets.

Authors:  T Fujimoto; S Ohara; J Hawiger
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

10.  Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent.

Authors:  L De Marco; S S Shapiro
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.